Affordable Prices Without Threatening the Oncological R&D Pipeline-An Economic Experiment on Transparency in Price Negotiations

The high prices of innovative medicines endanger access to care worldwide. Sustainable prices need to be affordable while sufficiently incentivizing research and development (R&D) investments. A proposed solution is increased transparency. Proponents argue that price and R&D cost confidentia...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research communications 2022-01, Vol.2 (1), p.49-57
Hauptverfasser:	Franzen, Nora, Ziegler, Andreas, Romagnoli, Giorgia, Retèl, Valesca P, Offerman, Theo J S, van Harten, Wim H
Format:	Artikel
Sprache:	eng
Schlagworte:	Health Policy Implementation Science Methodology And Modeling Regulatory Science Translational Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!